PRESS RELEASE published on 05/28/2025 at 07:30, 11 months 12 days ago Inside Information / Other news releases New clinical and scientific data on TWYMEEG® to be presented at the 68th Annual Meeting of the Japan Diabetes Society, showcasing efficacy, safety, and benefits in diverse patient groups Clinical Data Scientific Data TWYMEEG® Sumitomo Pharma Japan Diabetes Society
BRIEF published on 05/13/2025 at 07:35, 11 months 27 days ago Poxel's First Quarter 2025 Revenue and Business Developments Regulatory Approval Corporate Strategy Poxel Revenue TWYMEEG® Sales Royalties Increase
PRESS RELEASE published on 05/13/2025 at 07:30, 11 months 27 days ago Inside Information / Information on annual revenues Poxel reports consolidated revenue and corporate updates for Q1 2025, with TWYMEEG® sales growth in Japan and regulatory approval for diabetic patients with renal impairment Revenue Regulatory Approval Japan Poxel TWYMEEG
BRIEF published on 03/20/2025 at 21:50, 1 year 1 month ago Poxel Releases Positive Preclinical Results for HCM Treatment Preclinical Study Hypertrophic Cardiomyopathy PXL065 Myocardial Remodeling Cardiac Fibrosis
PRESS RELEASE published on 03/20/2025 at 21:45, 1 year 1 month ago Inside Information / Other news releases Poxel announces positive preclinical study results for PXL065, a potential treatment for Hypertrophic Cardiomyopathy, showing benefits in a mouse model Preclinical Study Poxel Hypertrophic Cardiomyopathy PXL065 Mouse Model
BRIEF published on 02/11/2025 at 20:33, 1 year 2 months ago Poxel Holds Combined General Meeting, Announces Key Results General Meeting Shareholder Voting Financial Delegations Remuneration Policy Poxel SA
PRESS RELEASE published on 02/11/2025 at 20:28, 1 year 2 months ago Inside Information / Other news releases Poxel announces results of its Combined General Meeting with approved resolutions on revised remuneration policy for corporate officers. Details available on company's website Voting Results Financial Press Release Combined General Meeting Poxel Remuneration Policy
BRIEF published on 01/31/2025 at 07:35, 1 year 3 months ago POXEL Announces Growing Sales of TWYMEEG in Japan for 2024 Poxel Sumitomo Pharma TWYMEEG Japan Sales 2024 Revenues
BRIEF published on 01/20/2025 at 07:35, 1 year 3 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
Published on 05/09/2026 at 01:30, 18 hours 52 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 20 hours 22 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 1 hour 16 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 23 hours 43 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 1 hour ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 1 hour ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 1 hour ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 2 days 1 hour ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 2 days 2 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 2 days 2 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
